carcinoma, neuroendocrine

Showing 1 - 11 of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neuroendocrine Carcinomas, Neuroendocrine Tumors, Carcinoma, Neuroendocrine Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Neuroendocrine Carcinomas
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Sep 22, 2023

Neuroendocrine Neoplasms Including Adrenocortical Carcinoma

Recruiting
  • Neuroendocrine Tumors
  • Carcinoma, Neuroendocrine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

    Active, not recruiting
    • RET-altered Non Small Cell Lung Cancer
    • +39 more
    • pralsetinib (BLU-667)
    • Phoenix, Arizona
    • +65 more
    Nov 10, 2022

    Sarcoma, Ovarian Tumor, CNS Tumor Trial in Villejuif (Pembrolizumab)

    Active, not recruiting
    • Sarcoma
    • +6 more
    • Villejuif, France
      Gustave Roussy Cancer Campus
    Mar 28, 2022

    Colorectal Cancer, Carcinoma, Neuroendocrine, Tumor Metastasis Trial in United States (Yttrium 90 glass microspheres)

    Completed
    • Colorectal Cancer
    • +2 more
    • Yttrium 90 glass microspheres
    • Chicago, Illinois
    • +4 more
    Apr 19, 2021

    Carcinoma, Neuroendocrine Trial in Edmonton ([177]Lu-DOTA-TATE)

    Recruiting
    • Carcinoma, Neuroendocrine
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Apr 12, 2021

    Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Tumors Trial run by the NCI (Sunitinib, Everolimus)

    Terminated
    • Neuroendocrine Tumors
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2020

    Neuroendocrine Tumors, Carcinoid Tumor, Carcinoma, Neuroendocrine Trial in Quebec City (177Lu-Octreotate)

    Recruiting
    • Neuroendocrine Tumors
    • +2 more
    • Quebec City, Quebec, Canada
      CHU de Québec - Université Laval
    Jul 15, 2020

    Carcinoma, Neuroendocrine Trial in Canton (Selinexor)

    Completed
    • Carcinoma, Neuroendocrine
    • Canton, Ohio
      Gabrail Cancer Center Research
    Sep 13, 2019

    Carcinoma, Neuroendocrine Trial in Toronto (Everolimus)

    Unknown status
    • Carcinoma, Neuroendocrine
    • Toronto, Ontario, Canada
      Odette Cancer Centre, Sunnybrook Health Science Centre
    Jul 22, 2016

    Gastrointestinal Cancer, Carcinoma, Neuroendocrine Trial in Houston (Cisplatin, Irinotecan)

    Completed
    • Gastrointestinal Cancer
    • Carcinoma, Neuroendocrine
    • Houston, Texas
      U.T. M.D. Anderson Cancer Center
    Aug 1, 2012